Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Epigenomics AG

+ Add to Watchlist

ECX:GR

5.532 EUR 0.289 4.96%

As of 15:35:03 ET on 04/01/2015.

Snapshot for Epigenomics AG (ECX)

Open: 5.796 Day's Range: 5.480 - 5.960 Volume: 146,471
Previous Close: 5.821 52wk Range: 2.800 - 7.267 1-Yr Rtn: -7.80%

Stock Chart for ECX

No chart data available.
  • ECX:GR 5.560
  • 1D
  • 1M
  • 1Y
5.821
Interactive ECX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.7430
Est. EPS (EUR) (12/2015) -0.4750
Est. PEG Ratio -
Market Cap (M EUR) 87.89
Shares Outstanding (M) 15.89
30 Day Average Volume 127,755
Price/Book (mrq) 24.7204
Price/Sale (ttm) 40.2141
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ECX

Epigenomics AG is a molecular diagnostics company developing and commercializing a pipeline of proprietary products for cancer. The Company's products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients.

Thomas TaapkenCEO/CFO/Member-Mgmt BoardUwe StaubChief Operating Officer
Antje ZeiseManager:Investor Relations
More Company Profile & Key Executives for ECX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil